01 - Quality indicators in primary care / Measurement and monitoring of treatment quality.
2022
Quality and variation of care for chronic kidney disease in Swiss general practice: A retrospective database study
Jäger L, Rosemann T, Burgstaller JM, Senn O, Markun S
PLoS One. 2022 Aug 11;17(8):e0272662.
Quality outcome of diabetes care during COVID-19 pandemic: a primary care cohort study
Di Gangi S, Lüthi B, Diaz Hernandez L, Zeller A, Zechmann S, Fischer R
Acta Diabetologica volume 59, pages 1189–1200 (2022).
2021
Long-Term Effects of Financial Incentives for General Practitioners on Quality Indicators in the Treatment of Patients With Diabetes Mellitus in Primary Care—A Follow-Up Analysis of a Cluster Randomized Parallel Controlled Trial
Meier R, Chmiel C, Valeri F, Muheim L, Senn O, Rosemann T
The Effect of Financial Incentives on Quality Measures in the Treatment of Diabetes Mellitus: a Randomized Controlled Trial
Meier R, Chmiel C, Valeri F, Muheim L, Senn O, Rosemann T
Journal of General Internal Medicine volume 37, pages 556–564
Physician-dispensing as a determinant of clinical and process measurements in patients at increased cardiovascular risk: A cross-sectional study in Swiss general practice
Rachamin Y, Meier R, Valeri F, Rosemann T, Muheim L
Health Policy Volume 125, Issue 10, October 2021, Pages 1305-1310
Inferior control of low-density lipoprotein cholesterol in women is the primary sex difference in modifiable cardiovascular risk: A large-scale, cross-sectional study in primary care
Rachamin Y, Grischott T, Rosemann T, Meyer MR
Atherosclerosis. 2021;324:141-147
2020
Guideline Concordance of Statin Treatment Decisions: A Retrospective Cohort Study
Rachamin Y, Markun S, Grischott T, Rosemann T, Meier R
J Clin Med. 2020;9(11):3719
The Impact of the 2019 European Guideline for Cardiovascular Risk Management: A Cross-Sectional Study in General Practice
Meier R, Rachamin Y, Rosemann T, Markun S
J Clin Med. 2020;9(7):2140
Statin treatment and LDL target value achievement in Swiss general practice – a retrospective observational study
Rachamin Y, Meier R, Rosemann T, Langenegger S, Markun S
Swiss Med Wkly. 2020;150:w20244
Quality performance and associated factors in Swiss diabetes care – A cross-sectional study
Meier R, Valeri F, Senn O, Rosemann T, Chmiel C
PLoS One. 2020;15(5):e0232686
Gout management in Swiss primary care – a retrospective observational study
Meier R, Di Gangi S, Valeri F, Rosemann T, Zechmann S, and the FIRE study group
Swiss Med Wkly. 2020;150:w20209
2019
Indications and associated factors for prescribing intravenous iron supplementation in Swiss general practice: a retrospective observational study
Meier R, Keizer E, Rosemann T, Markun S
Swiss Med Wkly. 2019;149:w20127
2017
Aspects of the quality of care for patients with PAD
Ursprung N, Senn O, Djalali S
Z Allg Med. 2017;93(12)
The impact of an individualized risk-adjusted approach on hypertension treatment in primary care
Zechmann S, Senn O, Valeri F, Neuner-Jehle S, Rosemann T, Djalali S and the FIRE study group
J Clin Hypertens (Greenwich). 2017;19(5):510-518
Anticoagulation Control in Swiss Primary Care: Time in Therapeutic Range Percentages Exceed Benchmarks of Phase III Trials
Djalali S, Valeri F, Gerber B, Meli DN, Senn O
Clin Appl Thromb Hemost. 2017;23(6):685-695
2016
Quality of secondary prevention of coronary heart disease in Swiss primary care: Lessons learned from a 6-year observational study
Scherz N, Valeri F, Rosemann T, Djalali S
Z Evid Fortbild Qual Gesundhwes. 2016;118-119:40-7
2015
General Practitioners’ vitamin K antagonist monitoring is associated with better blood pressure control in patients with hypertension – a cross-sectional database study
Streit S, Kaplan V, Busato A, Djalali S, Senn O, Meli DN and the FIRE study group
BMC Cardiovasc Disord. 2015;15(1):47
2014
Swiss Quality and Outcomes Framework: Quality Indicators for Diabetes Management in Swiss Primary Care Based on Electronic Medical Records
Djalali S, Frei A, Tandjung R, Baltensperger A, Rosemann T